Campbell Newman Asset Management Inc Halozyme Therapeutics, Inc. Transaction History
Campbell Newman Asset Management Inc
- $1.17 Billion
- Q4 2024
A detailed history of Campbell Newman Asset Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 34,373 shares of HALO stock, worth $1.99 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
34,373
Previous 34,558
0.54%
Holding current value
$1.99 Million
Previous $1.98 Million
16.89%
% of portfolio
0.14%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
547Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$770 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$417 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$242 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$200 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.08B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...